Seres Therapeutics, Inc. Ttl Offset Amt
Seres Therapeutics, Inc. (MCRB) had Ttl Offset Amt of $0 as of 2026-08-13, per its S-3 filed 2026-08-13.
Financial Statements › Notes
ffd:TtlOffsetAmt · last filed 2026-08-13
- 2026-08-13: Ttl Offset Amt $0.00.
- 2026-07-08: Ttl Offset Amt $0.00.
| Period end | Ttl Offset Amt |
|---|---|
| 2026-08-13 | $0.00 S-3 · filed 2026-08-13 |
| 2026-07-08 | $0.00 S-8 · filed 2026-07-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |